50 related articles for article (PubMed ID: 1665422)
1. The role of cyclic nucleotide mediators in latency and reactivation of HSV-1 infected neuroblastoma cells.
Rodriguez A; Sainz De La Maza M; Missry J; Foster CS
Eye (Lond); 1991; 5 ( Pt 5)():627-35. PubMed ID: 1665422
[TBL] [Abstract][Full Text] [Related]
2. Cyclic nucleotide modulation of herpes simplex virus latency and reactivation.
Sainz de la Maza M; Wells PA; Foster CS
Invest Ophthalmol Vis Sci; 1989 Oct; 30(10):2154-9. PubMed ID: 2551836
[TBL] [Abstract][Full Text] [Related]
3. Evidence for the potential influence of cyclic nucleotides on maintenance of or reactivation from latency of herpes simplex virus in trigeminal ganglionic neurons.
Foster CS; Opremcak EM; Tolchin N
Acta Ophthalmol Suppl (1985); 1989; 192():142-4. PubMed ID: 2554643
[TBL] [Abstract][Full Text] [Related]
4. Effect of hexamethylene bisacetamide and cyclosporin A on recovery of herpes simplex virus type 2 from the in vitro model of latency in a human neuroblastoma cell line.
Kondo Y; Yura Y; Iga H; Yanagawa T; Yoshida H; Furumoto N; Sato M
Cancer Res; 1990 Dec; 50(24):7852-7. PubMed ID: 2174735
[TBL] [Abstract][Full Text] [Related]
5. The effect of topical ocular corticosteroid administration in dogs with experimentally induced latent canine herpesvirus-1 infection.
Ledbetter EC; Kice NC; Matusow RB; Dubovi EJ; Kim SG
Exp Eye Res; 2010 Jun; 90(6):711-7. PubMed ID: 20223234
[TBL] [Abstract][Full Text] [Related]
6. Neuronal control of herpes simplex virus latency.
Tenser RB; Edris WA; Hay KA
Virology; 1993 Aug; 195(2):337-47. PubMed ID: 8393231
[TBL] [Abstract][Full Text] [Related]
7. [Establishment of a cell model system of herpes simplex virus type II latent infection and reactivation in SH-SY5Y cells].
Sun Z; Yang H; Shi Y; Wei M; Xian J; Hu W
Wei Sheng Wu Xue Bao; 2010 Jan; 50(1):98-106. PubMed ID: 20344947
[TBL] [Abstract][Full Text] [Related]
8. Ocular herpes simplex virus reactivation in mice latently infected with latency-associated transcript mutants.
Cook SD; Paveloff MJ; Doucet JJ; Cottingham AJ; Sedarati F; Hill JM
Invest Ophthalmol Vis Sci; 1991 Apr; 32(5):1558-61. PubMed ID: 1849874
[TBL] [Abstract][Full Text] [Related]
9. Reactivation of murine latent HSV infection by epinephrine iontophoresis.
Willey DE; Trousdale MD; Nesburn AB
Invest Ophthalmol Vis Sci; 1984 Aug; 25(8):945-50. PubMed ID: 6086546
[TBL] [Abstract][Full Text] [Related]
10. Ganglionic permissivity to HSV-1 replication and acyclovir-induced latency: an in vitro model.
Millin JA; Opremcak EM; Wells PA; Foster CS
Invest Ophthalmol Vis Sci; 1988 Feb; 29(2):232-8. PubMed ID: 2828264
[TBL] [Abstract][Full Text] [Related]
11. Herpes simplex virus latency-associated transcript sequence downstream of the promoter influences type-specific reactivation and viral neurotropism.
Bertke AS; Patel A; Krause PR
J Virol; 2007 Jun; 81(12):6605-13. PubMed ID: 17409161
[TBL] [Abstract][Full Text] [Related]
12. Mutagenesis of a cAMP response element within the latency-associated transcript promoter of HSV-1 reduces adrenergic reactivation.
Bloom DC; Stevens JG; Hill JM; Tran RK
Virology; 1997 Sep; 236(1):202-7. PubMed ID: 9299632
[TBL] [Abstract][Full Text] [Related]
13. The development of an improved murine iontophoresis reactivation model for the study of HSV-1 latency.
Gordon YJ; Araullo-Cruz TP; Romanowski E; Ruziczka L; Balouris C; Oren J; Cheng KP; Kim S
Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1230-4. PubMed ID: 3015823
[TBL] [Abstract][Full Text] [Related]
14. [The mechanisms for latency and reactivation of alpha herpesviridae].
Yoshikawa T
Nihon Rinsho; 2000 Apr; 58(4):807-14. PubMed ID: 10774199
[TBL] [Abstract][Full Text] [Related]
15. Treatment of HSV-1 infection with immunoglobulin or acyclovir: comparison of their effects on viral spread, latency, and reactivation.
LeBlanc RA; Pesnicak L; Godleski M; Straus SE
Virology; 1999 Sep; 262(1):230-6. PubMed ID: 10489356
[TBL] [Abstract][Full Text] [Related]
16. Correlation between herpes simplex virus type 1 rate of reactivation from latent infection and the number of infected neurons in trigeminal ganglia.
Maggioncalda J; Mehta A; Su YH; Fraser NW; Block TM
Virology; 1996 Nov; 225(1):72-81. PubMed ID: 8918535
[TBL] [Abstract][Full Text] [Related]
17. HSV-1 migration in latently infected and naive rabbits after penetrating keratoplasty.
Zheng X; Marquart ME; Loustch JM; Shah P; Sainz B; Ray A; O'Callaghan RJ; Kaufman HE; Hill JM
Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2490-7. PubMed ID: 10509641
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of herpes simplex virus reactivation by dipyridamole in a mouse model.
Hay KA; Gaydos A; Tenser RB
J Med Virol; 1996 Oct; 50(2):198-203. PubMed ID: 8915888
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of oral herpes simplex virus reactivation in cancer patients: a comparison of different techniques of viral detection.
Djuric M; Jankovic L; Jovanovic T; Pavlica D; Brkic S; Knezevic A; Markovic D; Milasin J
J Oral Pathol Med; 2009 Feb; 38(2):167-73. PubMed ID: 18713235
[TBL] [Abstract][Full Text] [Related]
20. Early intervention with high-dose acyclovir treatment during primary herpes simplex virus infection reduces latency and subsequent reactivation in the nervous system in vivo.
Sawtell NM; Thompson RL; Stanberry LR; Bernstein DI
J Infect Dis; 2001 Oct; 184(8):964-71. PubMed ID: 11574910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
